Key details
Collaborators
European Respiratory Society, AstraZeneca
Enrollment target
~1,000 participants
Primary completion
December 2025
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years and older
Last updated November 2024